Glucagon me… n=1 experiments with microbolusing glucagon part 2: quantifying use
Are two hormones and an algorithm enough? Or is diabetes far more complex than that?
Blog Posts
Glucagon me… n=1 experiments with microbolusing Glucagon part 1: setting a baseline
Everyone with type 1 is taught that the big orange plastic box that we’re supposed to keep in the fridge is for emergencies only and […]
Eyecare or iCare? A revolution in the eye screening world.
One of the stands in the Exhibition Hall that stood out was a smaller one, inhabited by a company known as iCare. Perhaps unsurprisingly, their […]
How far are we from fully closed loop? News from ATTD 2023
One of the great things about the ATTD conference is the updates on the technologies that are upcoming, alongside the “What’s already there”. It’s very […]
Why Aidex shouldn’t be on a Formulary. Anywhere.
You may remember, back in the summer of 2022, the author of this site wore an Aidex system (distributed by GlucoRX in the UK) to […]
Tidepool Loop. Approved but not yet available
With the recent news that Tidepool’s Loop has been approved by the FDA, the detail, that there are no pumps available that work with it, […]
Back-smoothing or not back-smoothing? Is that the question?
As many will have seen, the Dexcom G7 never had, and recently the G6, has removed back-smoothing from the apps on the phone, for various […]
Further observations of Dexcom’s G7.
Having tested a G7 against the Libre3, and found that without calibration, it tended to produce results that I wasn’t satisfied with using just the […]
Battle Royale – Freestyle Libre 3 and Dexcom G7 face off – The results
As previously discussed in this article, I have been wearing the Libre 3, Dexcom G6 and G7, to compare performance across all three. These are […]
The art of CGM accuracy studies, part 2: The Freestyle Libre3
As I’m currently testing a Libre3, and have taken a look back at the various accuracy studies as a part of this to review MARD data, […]